MRI Screening in Men at High Risk of Developing Prostate Cancer
Recruiting · NCT05608694 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Chicago
View the official record on ClinicalTrials.gov →Interventions studied
Prostate MRI
What this trial is about
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male age 18 and older
- No known history of prostate cancer
- No previous prostate resection or ablation (e.g. TURP, photovaporization)
Exclusion criteria
- Unable to tolerate MRI due to metal fragments or claustrophobia
- Lack of a rectum
- Hip arthroplasty
Where it is running
2 locations listed across 1 US state.
- University of Chicago - Chicago, Illinois, United States
- NorthShore University Health System - Glenbrook Hospital - Glenview, Illinois, United States